What's in Celon Pharma SA's pipeline?

Celon Pharma SA has 10 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 7 in Phase 2, 3 in Phase 1.

Which companies overlap with Celon Pharma SA's portfolio?

Top competitors by shared drug class: AstraZeneca, Beijing Tiantan Hospital, AJU Pharm Co., Ltd., Abbott, Acacia Pharma Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/celon-pharma-sa.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Celon Pharma SA — Portfolio Competitive Intelligence Brief

Celon Pharma SA pipeline: 0 marketed, 0 filed, 0 Phase 3, 7 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 7 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Diabetes · 2
Psychiatry / Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 2 shared drug classes
Beijing Tiantan Hospital · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Abbott · 1 shared drug class
Acacia Pharma Ltd · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
AO GENERIUM · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Celon Pharma SA:

Cite this brief

Drug Landscape (2026). Celon Pharma SA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/celon-pharma-sa. Accessed 2026-05-13.